# PATINA (NCT02947685)

> Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02947685
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Alliance Foundation Trials, LLC.
- Conditions: HER-2 Positive Breast Cancer; Estrogen Receptor Positive Breast Cancer
- Interventions: palbociclib; trastuzumab; pertuzumab; letrozole; Anastrozole; Exemestane; Fulvestrant
- Enrollment: 518
- Primary outcome: Progression-free Survival (PFS) as Assessed by Investigator

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 174
- YouTube: 154
- Podcasts: 87
- X videos: 9

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=patina-nct02947685

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02947685", "email": "<work email>"}; the inbox owner confirms by the emailed link.